NEIL RAVIN, MD
Specialist in HAVERHILL, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
NEIL RAVIN, MD filed 3,171 Medicare Part D claims in 2023 as a Specialist in HAVERHILL, Massachusetts, prescribing 47% generic.
- 3K
- Part D claims, 2023
- 47%
- generic prescribing
- $31.16
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
NEIL RAVIN, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,171 Top 11% higher than 89% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about NEIL RAVIN, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Specialist compares to other specialties among Massachusetts providers
Specialist share within Massachusetts
Specialist is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Specialist ABMS/AOA estimate
Est. board-certified rate (Specialist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Specialist US NPIs
Specialty board-certified rate — Specialist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
NEIL RAVIN, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 62 BROWN ST, HAVERHILL, MA, 01830, with a listed phone of (978) 478-5030. NPI 1043304249 was issued on 10/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAVIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,171 prescription claims written by this provider, covering 348 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 53% brand-name and 47% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1043304249 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/03/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm NEIL RAVIN, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NEIL RAVIN, MD. Source: openpaymentsdata.cms.gov.
Total received
$31
Largest payer
Abbott Laboratories
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to NEIL RAVIN, MD. To verify NEIL RAVIN, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
53% brand-name claims vs 47% generic, on 3,171 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,460
- Total Day Supply
- 221,527
- Brand vs Generic
- 53% brand / 47% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $30K
Patient Demographics
- Average Patient Age
- 70.1 years
- Avg HCC Risk Score
- 1.49
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 69, 65-74: 161, 75-84: 104, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What NEIL RAVIN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
332 claims
- Metformin Hcl
Metformin Hcl
330 claims
- Farxiga
Farxiga
240 claims
- Jardiance
Jardiance
192 claims
- Trulicity
Trulicity
141 claims
- Glimepiride 130
Glimepiride
130 claims
- Mounjaro 99
Mounjaro
99 claims
- Novolin N Flexpen 82
Novolin N Flexpen
82 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 332 |
| Metformin Hcl | 330 |
| Farxiga Dapagliflozin Propanediol | 240 |
| Jardiance Empagliflozin | 192 |
| Trulicity Dulaglutide | 141 |
| Glimepiride | 130 |
| Mounjaro Tirzepatide | 99 |
| Novolin N Flexpen Insulin Nph Human Isophane | 82 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 81 |
| Novolin N Insulin Nph Human Isophane | 80 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How NEIL RAVIN, MD fits within the Specialist landscape nationally.
NEIL RAVIN, MD's 3,171 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as RAVIN.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is NEIL RAVIN, MD's specialty? ▼
How much does NEIL RAVIN, MD prescribe under Medicare Part D? ▼
Where is NEIL RAVIN, MD located? ▼
What is NEIL RAVIN, MD's NPI number? ▼
Does NEIL RAVIN, MD prescribe more brand-name or generic drugs? ▼
How many Specialist providers are there in the US? ▼
What drugs does NEIL RAVIN, MD prescribe most often? ▼
Does NEIL RAVIN, MD accept Medicare? ▼
How can I verify NEIL RAVIN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology